{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:34:40Z","timestamp":1786523680036,"version":"build-2736575974"},"reference-count":90,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Extramammary Paget disease (EMPD) is a rare epithelial malignancy that arises in the apocrine gland-bearing skin. Although localized intraepidermal EMPD generally follows an indolent clinical course, invasive EMPD is associated with lymph node metastasis, distant dissemination, and poor survival. Owing to its rarity, high-level evidence is limited and treatment strategies remain incompletely standardized, particularly for advanced disease. Recent advances in molecular profiling have revealed actionable therapeutic targets and created new opportunities for precision medicine. Methods: A narrative review was conducted using the PubMed database through May 2026. Relevant literature regarding the epidemiology, prognostic factors, surgical and non-surgical management, lymph node management, radiotherapy, systemic therapies, molecularly targeted therapies, and future therapeutic directions for EMPD is reviewed and summarized. Results: Surgical excision remains the standard treatment for resectable localized EMPD. Margin-controlled approaches, including Mohs micrographic surgery, complete circumferential peripheral and deep margin assessments, and mapping biopsy-guided excision, have contributed to improved local disease control. Radiotherapy, topical imiquimod, and photodynamic therapy provide alternative treatment options for patients who are unsuitable candidates for surgery; however, recurrence remains a major challenge. The management of regional lymph node metastases includes sentinel lymph node biopsy, lymph node dissection, and adjuvant radiotherapy in selected patients. For metastatic disease, conventional chemotherapy based on taxanes and fluoropyrimidine\/platinum combinations has demonstrated moderate antitumor activity but limited durability. Molecular characterization of EMPD has identified several promising therapeutic targets. HER2 overexpression or amplification, observed in approximately 30\u201340% of cases, has emerged as the most clinically validated biomarker, with trastuzumab-based therapies demonstrating substantial efficacy. Immune checkpoint inhibitors have shown activity in selected patients, particularly those with a high tumor mutational burden, although predictive biomarkers remain inadequately defined. Additional emerging targets include androgen receptor signaling, TROP2, NECTIN4, FOXM1, and PIK3CA-associated pathways. Conclusions: In addition to conventional surgery- and chemotherapy-based approaches, biomarker-driven precision oncology is gaining attention as a treatment strategy for EMPD. HER2-targeted therapies, antibody\u2013drug conjugates, and rationally selected immunotherapeutic strategies are expected to play increasingly important roles in the treatment of advanced disease. Continued translational research, international collaboration, and prospective clinical trials are essential to establish evidence-based treatment algorithms and improve outcomes in patients with this rare but potentially aggressive malignancy.<\/jats:p>","DOI":"10.3390\/cancers18162587","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:30:32Z","timestamp":1786465832000},"page":"2587","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Strategies for Extramammary Paget Disease: A Narrative Review of Current Status and Future Directions"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7983-9746","authenticated-orcid":false,"given":"Azusa","family":"Miyashita","sequence":"first","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-7682","authenticated-orcid":false,"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.36849\/jdd.0823","article-title":"EXTRA, EXTRA, Treatment Approaches for EXTRAmammary Paget Disease","volume":"22","author":"Desai","year":"2023","journal-title":"J. Drugs Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3390\/curroncol28040260","article-title":"Extramammary Paget\u2019s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments","volume":"28","author":"Ishizuki","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/1346-8138.17855","article-title":"Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Extramammary Paget Disease 2025","volume":"52","author":"Matsushita","year":"2025","journal-title":"J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/jamaoncol.2021.7148","article-title":"Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease","volume":"8","author":"Kibbi","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jcp.53.10.742","article-title":"Mammary and extramammary Paget\u2019s disease","volume":"53","author":"Lloyd","year":"2000","journal-title":"J. Clin. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Weng, S., Zhu, N., Li, D., Chen, Y., Tan, Y., Chen, J., and Yuan, Y. (2020). Clinical Characteristics, Treatment, and Prognostic Factors of Patients with Primary Extramammary Paget\u2019s Disease (EMPD): A Retrospective Analysis of 44 Patients from a Single Center and an Analysis of Data from the Surveillance, Epidemiology, and End Results (SEER) Database. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01114"},{"key":"ref_7","first-page":"1077","article-title":"Perianal Paget\u2019s disease: Distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression","volume":"122","author":"Nowak","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s11864-021-00923-3","article-title":"Current Management and Treatment of Extramammary Paget\u2019s Disease","volume":"23","author":"Hashimoto","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1346-8138.70125","article-title":"Real-World Efficacy of Chemotherapy in Patients with Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients","volume":"53","author":"Miyashita","year":"2026","journal-title":"J. Dermatol."},{"key":"ref_10","first-page":"7","article-title":"Epidemiologic survey of malignant skin tumor-international comparison between Japan and foreign countries","volume":"71","author":"Fujisawa","year":"2013","journal-title":"Nihon Rinsho"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jdermsci.2016.06.004","article-title":"A proposal for a TNM staging system for extramammary Paget disease: Retrospective analysis of 301 patients with invasive primary tumors","volume":"83","author":"Ohara","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/cas.15823","article-title":"Epidemiology of skin cancer based on Japan\u2019s National Cancer Registry 2016\u20132017","volume":"114","author":"Ogata","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/1346-8138.14247","article-title":"Efficacy of low-dose 5-fluorouracil\/cisplatin therapy for invasive extramammary Paget\u2019s disease","volume":"45","author":"Kato","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5227\/skincancer.8.Special_187","article-title":"Diagnosis and treatment of extramammary Paget\u2019s disease","volume":"8","author":"Ohata","year":"1993","journal-title":"Skin Cancer"},{"key":"ref_15","first-page":"313","article-title":"Extramammary Paget\u2019s disease: Treatment, prognostic factors and outcome in 76 patients","volume":"158","author":"Hatta","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11912-023-01434-0","article-title":"Extramammary Paget Disease: A Therapeutic Challenge, for a Rare Entity","volume":"25","author":"Perez","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-018-0545-x","article-title":"Surgical Treatment for Extramammary Paget\u2019s Disease","volume":"19","author":"Wollina","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2147\/CCID.S516022","article-title":"Narrow-Margin Treatment with Modified Mohs Microsurgery for Extramammary Paget\u2019s Disease: A Retrospective Clinical Analysis","volume":"18","author":"Yang","year":"2025","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1016\/j.asjsur.2023.01.079","article-title":"The clinical effect of modified slow Mohs circular skin biopsy on penoscrotal extramammary Paget\u2019s disease","volume":"46","author":"Song","year":"2023","journal-title":"Asian J. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1245\/s10434-017-5947-7","article-title":"Usefulness of Mapping Biopsy in the Treatment of Penoscrotal Extramammary Paget\u2019s Disease","volume":"24","author":"Park","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4111\/kju.2013.54.12.834","article-title":"Extramammary Paget Disease of External Genitalia: Surgical Excision and Follow-up Experiences with 19 Patients","volume":"54","author":"Jung","year":"2013","journal-title":"Korean J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/1346-8138.12347","article-title":"Mapping biopsy with punch biopsies to determine surgical margin in extramammary Paget\u2019s disease","volume":"40","author":"Kato","year":"2013","journal-title":"J. Dermatol."},{"key":"ref_23","first-page":"379","article-title":"Clinical analysis of 65 patients with extramammary Paget\u2019s disease at Department of Dermatology, Fukushima Medical University between 2006 and 2017","volume":"75","author":"Ikari","year":"2021","journal-title":"Jpn. J. Clin. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/bjd.13357","article-title":"Postoperative radiation therapy for extramammary Paget\u2019s disease","volume":"172","author":"Hata","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000358161","article-title":"Radiotherapy in patients with extramammary Paget\u2019s disease\u2014Our own experience and review of the literature","volume":"37","author":"Itonaga","year":"2014","journal-title":"Oncol. Res. Treat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/IGC.0000000000001237","article-title":"The Role of Radiotherapy in Extramammary Paget Disease: A Systematic Review","volume":"28","author":"Tagliaferri","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/postmj\/qgaf109","article-title":"A retrospective study on Mohs micrographic surgery combined with adjuvant radiotherapy in the treatment of extramammary Paget\u2019s disease: Analysis of 87 patients","volume":"102","author":"Zhang","year":"2026","journal-title":"Postgrad. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101958","DOI":"10.1016\/j.adro.2025.101958","article-title":"Efficacy of Radiation Therapy in 106 Patients with Extramammary Paget Disease: A Retrospective Study","volume":"11","author":"Min","year":"2026","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2016.04.028","article-title":"A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget\u2019s disease","volume":"142","author":"Cowan","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mayo-Martinez, F., Moro, R., Millan-Esteban, D., Rios-Vinuela, E., Bautista, I.J., Nagore, E., Sanmartin, O., and Llombart, B. (2023). Topical Imiquimod in Primary Cutaneous Extramammary Paget\u2019s Disease: A Systematic Review. Cancers, 15.","DOI":"10.3390\/cancers15235665"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/dth.12394","article-title":"Topical imiquimod in the treatment of extramammary Paget\u2019s disease: A 10 year retrospective analysis in an Asian tertiary centre","volume":"29","author":"Liau","year":"2016","journal-title":"Dermatol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.maturitas.2022.05.010","article-title":"Vulvar Paget\u2019s disease: Outcomes of 51 patients treated with imiquimod cream","volume":"163","author":"Borella","year":"2022","journal-title":"Maturitas"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"250.e1","DOI":"10.1016\/j.ajog.2022.04.012","article-title":"The Paget Trial: Topical 5% imiquimod cream for noninvasive vulvar Paget disease","volume":"227","author":"Bulten","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1346-8138.14117","article-title":"Imiquimod 5% cream as a therapeutic option for extramammary Paget\u2019s disease","volume":"45","author":"Sawada","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_35","first-page":"4492","article-title":"Applications of photodynamic therapy in extramammary Paget\u2019s disease","volume":"13","author":"Ren","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"101911","DOI":"10.1016\/j.pdpdt.2020.101911","article-title":"Photodynamic therapy for extramammary Paget\u2019s disease: A systematic review of the literature","volume":"31","author":"Shim","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105301","DOI":"10.1016\/j.pdpdt.2025.105301","article-title":"Photodynamic therapy for extramammary paget\u2019s disease: A retrospective analysis of 15 cases","volume":"56","author":"Chen","year":"2025","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"102670","DOI":"10.1016\/j.pdpdt.2021.102670","article-title":"Efficacy and safety of HpD-PDT for Extramammary Paget\u2019s Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study","volume":"37","author":"Wang","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102841","DOI":"10.1016\/j.pdpdt.2022.102841","article-title":"PDD-guided tumor excision combined with photodynamic therapy in patients with extramammary Paget\u2019s disease","volume":"38","author":"Li","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_40","first-page":"3315","article-title":"Definitive radiation therapy for extramammary Paget\u2019s disease","volume":"32","author":"Hata","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_41","first-page":"109","article-title":"External beam radiotherapy of extramammary Paget disease","volume":"95","author":"Tackenberg","year":"2015","journal-title":"Cutis"},{"key":"ref_42","first-page":"11","article-title":"Six Cases of Extramamammary Paget\u2019s Disease Treated with Radiotherapy","volume":"20","author":"Tanimura","year":"2021","journal-title":"Hifunokagaku"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/annonc\/mdt478","article-title":"Radiation therapy for extramammary Paget\u2019s disease: Treatment outcomes and prognostic factors","volume":"25","author":"Hata","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Niwa, M., Tomita, N., Ishiyama, H., Kaneko, H., Oshima, Y., Takano, H., Matsuo, M., Kuno, M., Miyakawa, A., and Otsuka, S. (2025). Clinical Outcomes and Prognostic Factors for Extramammary Paget\u2019s Disease Treated with Radiation Therapy: A Multi-Institutional Observational Study. Cancers, 17.","DOI":"10.3390\/cancers17091507"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1346-8138.16602","article-title":"Sentinel lymph node biopsy in extramammary Paget disease: A 13-year institutional experience","volume":"50","author":"Maeda","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00403-023-02649-8","article-title":"The role of sentinel lymph node biopsy in extramammary paget disease: A systematic review","volume":"315","author":"Faisel","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2015.03.014","article-title":"The role of sentinel lymph node biopsy in the management of invasive extramammary Paget\u2019s disease: Multi-center, retrospective study of 151 patients","volume":"79","author":"Fujisawa","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1684\/ejd.2016.2744","article-title":"Usefulness of sentinel lymph node biopsy for prognostic prediction in extramammary Paget\u2019s disease","volume":"26","author":"Ogata","year":"2016","journal-title":"Eur. J. Dermatol."},{"key":"ref_49","first-page":"2891","article-title":"Our Department\u2019s Experience in Treating Extramammary Paget\u2019s Disease over the Past 10 Years","volume":"122","author":"Kurooka","year":"2012","journal-title":"Jpn. J. Dermatol."},{"key":"ref_50","first-page":"1473","article-title":"Lymph Node Metastasis and Sentinel Lymph Node Biopsy in the Extramamary Paget\u2019s Disease","volume":"116","author":"Yoshino","year":"2006","journal-title":"Jpn. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/1346-8138.12173","article-title":"Possible effectiveness of lymph node dissection in patients with extramammary Paget\u2019s disease","volume":"40","author":"Matsushita","year":"2013","journal-title":"J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/1346-8138.12764","article-title":"Tumor thickness as a prognostic factor in extramammary Paget\u2019s disease","volume":"42","author":"Ito","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/1346-8138.15285","article-title":"Outcomes of lymph node dissection in the treatment of extramammary Paget\u2019s disease: A single-institution study","volume":"47","author":"Tsutsui","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/1346-8138.16491","article-title":"Postoperative radiation therapy improves prognoses in extramammary Paget\u2019s disease presenting with multiple lymph node metastases","volume":"49","author":"Okumura","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jdv.12185","article-title":"Radiation therapy for lymph node metastasis from extramammary Paget\u2019s disease","volume":"28","author":"Hata","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"15159","DOI":"10.1002\/cam4.6190","article-title":"Treatment outcomes of advanced\/metastatic extramammary Paget\u2019s disease in Korean patients: KCSG-RC20-06","volume":"12","author":"Sohn","year":"2023","journal-title":"Cancer Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.4081\/rt.2016.6804","article-title":"Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998\u20132012","volume":"8","author":"Padrnos","year":"2016","journal-title":"Rare Tumors"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/1346-8138.15255","article-title":"Weekly docetaxel monotherapy for metastatic extramammary Paget\u2019s disease: Retrospective single-institute analysis","volume":"47","author":"Nakamura","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1346-8138.13200","article-title":"Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget\u2019s disease","volume":"43","author":"Yoshino","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s10147-014-0686-2","article-title":"Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget\u2019s disease","volume":"20","author":"Tokuda","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e14993","DOI":"10.1111\/exd.14993","article-title":"Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial","volume":"33","author":"Maeda","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000514345","article-title":"Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report","volume":"14","author":"Guercio","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1346-8138.17500","article-title":"Extramammary Paget\u2019s disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failure","volume":"52","author":"Narasaki","year":"2025","journal-title":"J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Yamazaki, N., Namikawa, K., Uchi, H., Mori, S., Ogawa-Momohara, M., Fujimura, T., Takenouchi, T., Kurimoto, M., and Yamamoto, Y. (2026). Nivolumab for unresectable cutaneous epithelial malignancies: An open-label, single-arm, multi-centre, phase II trial (NMSC-PD1). BMC Cancer, 26.","DOI":"10.1186\/s12885-026-15829-2"},{"key":"ref_65","first-page":"e72592","article-title":"A Case of Advanced Extramammary Paget\u2019s Disease with a High Tumor Mutation Burden That Showed Partial Lymph Node Regression with Pembrolizumab","volume":"16","author":"Horisaki","year":"2024","journal-title":"Cureus"},{"key":"ref_66","first-page":"e37","article-title":"Absence of microsatellite instability in extramammary Paget\u2019s disease","volume":"1","author":"Myangat","year":"2021","journal-title":"Skin Health Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.18632\/oncotarget.27247","article-title":"Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer\/testis antigens NY-ESO-1 and MAGE-A","volume":"10","author":"Pourmaleki","year":"2019","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Mauzo, S.H., Tetzlaff, M.T., Milton, D.R., Siroy, A.E., Nagarajan, P., Torres-Cabala, C.A., Ivan, D., Curry, J.L., Hudgens, C.W., and Wargo, J.A. (2019). Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers, 11.","DOI":"10.3390\/cancers11060754"},{"key":"ref_69","first-page":"e86186","article-title":"A Case of Umbilical Invasive Extramammary Paget Disease with a High Tumor Mutational Burden Successfully Treated with Pembrolizumab","volume":"17","author":"Ishiguro","year":"2025","journal-title":"Cureus"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e1201","DOI":"10.1093\/oncolo\/oyae097","article-title":"Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget\u2019s disease (EMPD-HER2DOC)","volume":"29","author":"Hirai","year":"2024","journal-title":"Oncologist"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"104836","DOI":"10.1016\/j.critrevonc.2025.104836","article-title":"The role of HER2 pathway in vulvar paget\u2019s disease","volume":"214","author":"Pomati","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"oyaf235","DOI":"10.1093\/oncolo\/oyaf235","article-title":"Clinical and molecular landscape of metastatic extramammary Paget\u2019s disease","volume":"30","author":"Watanabe","year":"2025","journal-title":"Oncologist"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdermsci.2025.08.001","article-title":"Prevalence of FOXA1 and ERBB2 activating mutations in extramammary Paget\u2019s disease: A retrospective multicenter analysis of 99 cases from Japanese and Taiwanese cohorts","volume":"120","author":"Omi","year":"2025","journal-title":"J. Dermatol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdermsci.2019.03.006","article-title":"Identification of genetic alterations in extramammary Paget disease using whole exome analysis","volume":"94","author":"Kiniwa","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/PO.20.00073","article-title":"Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget\u2019s Disease of the Vulva","volume":"4","author":"Stasenko","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/1346-8138.15515","article-title":"Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget\u2019s disease: Four cases and a review","volume":"47","author":"Sekiguchi","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101754","DOI":"10.1016\/j.gore.2025.101754","article-title":"Trastuzumab monotherapy as maintenance treatment for metastatic HER2+ vulvar Paget disease: Systematic review and case report","volume":"59","author":"Incognito","year":"2025","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/modpathol.3800437","article-title":"Androgen receptors are frequently expressed in mammary and extramammary Paget\u2019s disease","volume":"18","author":"Liegl","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1309\/P756-XXCB-TV71-U4XV","article-title":"Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor","volume":"113","author":"Carcangiu","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.humpath.2015.07.007","article-title":"Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease","volume":"46","author":"Azmahani","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3768247","DOI":"10.1155\/2017\/3768247","article-title":"Mammary and Extramammary Paget\u2019s Disease Presented Different Expression Pattern of Steroid Hormone Receptors","volume":"2017","author":"Zhou","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2133.2005.06865.x","article-title":"Androgen-deprivation regimen for multiple bone metastases of extramammary Paget disease","volume":"153","author":"Yoneyama","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"oyaf063","DOI":"10.1093\/oncolo\/oyaf063","article-title":"Antibody-drug conjugate (disitamab vedotin) therapy targeting HER2-low or higher advanced extramammary Paget\u2019s disease","volume":"30","author":"Zhang","year":"2025","journal-title":"Oncologist"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41598-024-84566-y","article-title":"A multicenter study on TROP2 as a potential targeted therapy for extramammary Paget disease in Japan","volume":"15","author":"Ito","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e15049","DOI":"10.1111\/exd.15049","article-title":"NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease","volume":"33","author":"Tanaka","year":"2024","journal-title":"Exp. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Murata, M., Ito, T., Tanaka, Y., Kaku-Ito, Y., and Furue, M. (2020). NECTIN4 Expression in Extramammary Paget\u2019s Disease: Implication of a New Therapeutic Target. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165891"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"oyaf202","DOI":"10.1093\/oncolo\/oyaf202","article-title":"Carelizumab and rivoceranib for advanced extramammary Paget\u2019s disease: An investigator-initiated multicenter, single-arm, phase II trial","volume":"30","author":"Zhang","year":"2025","journal-title":"Oncologist"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1038\/s41598-024-54773-8","article-title":"FOXM1: A new therapeutic target of extramammary Paget disease","volume":"14","author":"Ito","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Takeichi, T., Okuno, Y., Matsumoto, T., Tsunoda, N., Suzuki, K., Tanahashi, K., Kono, M., Kikumori, T., Muro, Y., and Akiyama, M. (2020). Frequent FOXA1-Activating Mutations in Extramammary Paget\u2019s Disease. Cancers, 12.","DOI":"10.3390\/cancers12040820"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/acr-24-170","article-title":"PIK3CA inhibitor treatment for metastatic scrotal extramammary Paget\u2019s disease: A case report and literature review","volume":"9","author":"Huang","year":"2025","journal-title":"AME Case Rep."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2587\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:06:14Z","timestamp":1786521974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":90,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162587"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162587","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}